Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Contraceptive Drugs and Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Contraceptive Drugs and Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Contraceptive Drugs and Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Contraceptive Drugs and Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Contraceptive Drugs
4.3.1. Contraceptive Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Contraceptive Pills
4.3.2.1. Contraceptive Pills Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Patch
4.3.3.1. Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Injectable
4.3.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Contraceptive Devices
4.4.1. Contraceptive Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Condom
4.4.2.1. Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.2. Male Condom
4.4.2.2.1. Male Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.3. Female Condom
4.4.2.3.1. Female Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Subdermal Implants
4.4.3.1. Subdermal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Intrauterine Devices (IUDs)
4.4.4.1. Intrauterine Devices (IUDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.2. Copper IUDs
4.4.4.2.1. Copper IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.3. Hormonal IUDs
4.4.4.3.1. Hormonal IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Vaginal Ring
4.4.5.1. Vaginal Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.6. Diaphragm
4.4.6.1. Diaphragm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Contraceptive Drugs and Devices Market: Regional Estimates & Trend Analysis
5.1. Contraceptive Drugs and Devices Market Share, By Region, 2023 & 2030 (USD Billion)
5.2. North America
5.2.1. North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. UK
5.3.2.1. UK Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. Sweden
5.3.8.1. Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.9. Norway
5.3.9.1. Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Japan
5.4.2.1. Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. China
5.4.3.1. China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. India
5.4.4.1. India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. Australia
5.4.5.1. Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. South Korea
5.4.6.1. South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.7. Thailand
5.4.7.1. Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Argentina
5.5.3.1. Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. South Africa
5.6.2.1. South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. UAE
5.6.4.1. UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. Abbvie, Inc.
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. Afaxys, Inc.
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Agile Therapeutics
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. Bayer AG
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. China Resources (Holdings) Co., Ltd.
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. Church & Dwight Co., Inc.
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
6.4.7. Cupid Limited
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/ Strategic Initiatives
6.4.8. Helm AG
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/ Strategic Initiatives
6.4.9. Johnson & Johnson Services, Inc.
6.4.9.1. Participant’s Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Recent Developments/ Strategic Initiatives
6.4.10. Organon Group of Companies
6.4.10.1. Participant’s Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Recent Developments/ Strategic Initiatives
6.4.11. Pfizer Inc.
6.4.11.1. Participant’s Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Recent Developments/ Strategic Initiatives
6.4.12. Veru, Inc.
6.4.12.1. Participant’s Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Recent Developments/ Strategic Initiatives
6.4.13. Viatris Inc.
6.4.13.1. Participant’s Overview
6.4.13.2. Financial Performance
6.4.13.3. Product Benchmarking
6.4.13.4. Recent Developments/ Strategic Initiatives